Last $9.19 USD
Change Today -0.58 / -5.94%
Volume 442.5K
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for orasure technologies inc (OSUR)

Year over year, OraSure Technologies, Inc. has been able to grow their bottom line from a loss of $15.1M USD to a smaller loss of $11.2M USD primarily through revenue growth ($87.8M USD to $98.9M USD). For while the costs associated with cost of goods, SGA and income tax all increased as a percentage of sales, the growth in top line revenues contributed enough to still see net income improve.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Revenues75.081.987.898.9
TOTAL REVENUES75.081.987.898.9
Cost of Goods Sold27.729.332.240.4
GROSS PROFIT47.452.655.658.6
Selling General & Admin Expenses, Total37.740.459.968.7
R&D Expenses13.018.111.910.3
OTHER OPERATING EXPENSES, TOTAL50.758.571.879.1
OPERATING INCOME-3.4-5.9-16.3-20.5
Interest Expense-0.3-0.3-0.2--
NET INTEREST EXPENSE-0.3-0.3-0.2--
Other Non-Operating Income (Expenses)0.20.0-0.10.2
EBT, EXCLUDING UNUSUAL ITEMS-3.5-6.2-16.5-20.3
Merger & Restructuring Charges---3.50.0--
Other Unusual Items, Total------8.3
Other Unusual Items------8.3
EBT, INCLUDING UNUSUAL ITEMS-3.5-9.7-16.5-12.0
Income Tax Expense---0.9-1.4-0.8
Earnings from Continuing Operations-3.5-8.8-15.1-11.2
NET INCOME-3.5-8.8-15.1-11.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-3.5-8.8-15.1-11.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-3.5-8.8-15.1-11.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $9.19 USD -0.58

OSUR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akers Biosciences Inc $3.54 USD -0.1245
Chembio Diagnostics Inc $3.74 USD -0.04
Pernix Therapeutics Holdings Inc $8.31 USD -0.20
Quidel Corp $23.54 USD -0.93
Trinity Biotech PLC $18.54 USD -0.25
View Industry Companies
 

Industry Analysis

OSUR

Industry Average

Valuation OSUR Industry Range
Price/Earnings 100.0x
Price/Sales 4.8x
Price/Book 3.2x
Price/Cash Flow 121.2x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.